Yamaguchi JI

References (3)

Title : Preclinical metabolism and disposition of TP0473292, a novel oral prodrug of the potent metabotropic glutamate 2\/3 receptor antagonist TP0178894 for the treatment of depression - Inatani_2023_Drug.Metab.Dispos__
Author(s) : Inatani S , Ochi M , Kinoshita K , Yamaguchi JI , Endo H
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , : , 2023
Abstract :
PubMedSearch : Inatani_2023_Drug.Metab.Dispos__
PubMedID: 36754836

Title : Bottom-up physiologically based pharmacokinetic modeling for predicting the human pharmacokinetic profiles of the ester prodrug MGS0274 and its active metabolite MGS0008, a metabotropic glutamate 2\/3 receptor agonist - Ochi_2022_Xenobiotica__1
Author(s) : Ochi M , Kinoshita K , Yamaguchi JI , Endo H
Ref : Xenobiotica , :1 , 2022
Abstract :
PubMedSearch : Ochi_2022_Xenobiotica__1
PubMedID: 35296225

Title : Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2\/3 agonist with improved oral bioavailability - Urabe_2020_Eur.J.Med.Chem_203_112521
Author(s) : Urabe H , Miyakoshi N , Ohtake N , Nozoe A , Ochi M , Fukasawa M , Kinoshita K , Yamaguchi JI , Marumo T , Hikichi H , Chaki S , Hashihayata T
Ref : Eur Journal of Medicinal Chemistry , 203 :112521 , 2020
Abstract :
PubMedSearch : Urabe_2020_Eur.J.Med.Chem_203_112521
PubMedID: 32698110